Financial Analysis: Metastat (OTCMKTS:MTST) & SNDL (NASDAQ:SNDL)

SNDL (NASDAQ:SNDL) and Metastat (OTCMKTS:MTST) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, dividends and risk.

Risk & Volatility

SNDL has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500. Comparatively, Metastat has a beta of 291.19, suggesting that its share price is 29,019% more volatile than the S&P 500.

Profitability

This table compares SNDL and Metastat’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SNDL	-9.66%	-8.28%	-6.95%
Metastat	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings for SNDL and Metastat, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	1	0	1	0	2.00
Metastat	0	0	0	0	0.00

SNDL currently has a consensus target price of $4.50, indicating a potential upside of 198.01%. Given SNDL’s stronger consensus rating and higher possible upside, equities research analysts plainly believe SNDL is more favorable than Metastat.

Earnings & Valuation

This table compares SNDL and Metastat”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$951.58 million	0.41	-$69.18 million	($0.26)	-5.81
Metastat	N/A	N/A	N/A	N/A	N/A

Metastat has lower revenue, but higher earnings than SNDL.

About SNDL

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores. In addition, the company produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.

About Metastat

MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company’s therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.